FDA Approves Qfitlia™ (fitusiran), the First siRNA (RNAi Therapeutic) for the Treatment of Hemophilia A or B
On Mar. 28, 2025, the U.S. Food and Drug Administration (FDA) announced approval of Alnylam Pharmaceuticals Qfitlia™ (fitusiran),…
On Mar. 28, 2025, the U.S. Food and Drug Administration (FDA) announced approval of Alnylam Pharmaceuticals Qfitlia™ (fitusiran),…
On Mar. 27, 2025, Utah become the first state to ban fluoride in public drinking water, over opposition…
On Mar. 27, 2025, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On Mar. 26, 2025, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the…
On Mar. 25, 2025, Merck announced it has signed a licensing agreement for a heart disease drug with…
On Mar. 25, 2025, GSK announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin)…
On Mar. 24, 2025, LifeScienceHistory.com published the cartoon “Milestones in Fluoride” illustrating the facts behind the naturally occurring…
On Mar. 23, 2025, 23andMe announced that it has initiated voluntary Chapter 11 proceedings in the U.S. Bankruptcy…
On Mar. 20, 2025, Alnylam Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval of the supplemental…
On Mar. 14, 2025, researchers from the Walter and Eliza Hall Institute of Medical Research (WEHI) announced they…
On Mar. 11, 2025, researchers at St Vincent’s Hospital Sydney announced the first implant of a BiVACOR Total…
On Mar. 10, 2025, Beam Therapeutics announced initial safety and efficacy data from its Phase 1/2 trial of…
On Mar. 10, 2025, new research shows positive selection at the 2q21.3 locus in Europeans and Africans has…
On Mar. 6, 2025, researchers at the University of Cambridge announced they have discovered genes linked to obesity…
On Mar. 4, 2025, researchers at a Mass Eye and Ear Institute-led trial announced taking stem cells from…
On Mar. 3, 2025, the Institute for Health Metrics and Evaluation reported that without urgent policy reform and…
On Mar. 3, 2025, researchers from Oregon State University (OSU) announced the world’s first procedure successfully fixes lamb’s…
On Mar. 3, 2025, epidemiologists at the Texas A&M University School of Public Health have identified a link…
On Mar. 3, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase),…
On Mar. 3, 2025, researchers at Fred Hutch Cancer Center announced they have discovered an overlooked mechanism driving…
On Feb. 27, 2025, ALK announced that the U.S. Food and Drug Administration (FDA) has approved ALK’s ODACTRA®…
In Feb. 26, 2025, Eli Lilly announced that it plans to bolster its domestic medicine production across therapeutic…
On Feb. 24, 2025, breast cancer is the most common cancer in women worldwide, but survival chances vary…
On Feb. 21, 2025, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has determined the…
On Feb. 21, 2025, a team of researchers from the Marine Biological Laboratory (MBL) announced a hybrid custom-designed…
On Feb. 20, 2025, researchers from the University of Washington and Seattle Children’s Research Institute announced findings from…
On Feb. 19, 2025, Alcon announced the full U.S. commercial availability of Voyager™ DSLT, the first and only…
On Feb. 19, 2025, scientists at St. Jude Children’s Research Hospital report results from a promising new approach…
On Feb. 18, 2025, scientists from the Institute for Systems Biology announced they have developed a breakthrough method…
On Feb. 17, 2025, researchers from Texas Children’s Hospital in Houston announced that the four year old girl…